Promethegan Suppository
Product Images NDC 0713-0526

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Promethegan (NDC 0713-0526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12carton (12carton)

12carton (12carton)
PROMETHEGAN is a prescription medication in the form of suppositories that contains Promethazine HCI. It is intended to be administered rectally and is used for symptomatic treatment of various allergic conditions. Each package contains 12 suppositories. The product should be stored in a refrigerator between 2°-8°C (36°46°F) and disposed of in a well-closed container. The manufacturer is Cosatt Pharmacaucas, and the product is distributed with the GTIN 00307 130536127. More information about the product and distribution can be found on their website wncisataptarna.com.*
FDA Label Image

25carton (25carton)

25carton (25carton)
PROMETHEGAN™ ™ is a rectal suppository for Promethazine HCI that contains 25mg of promethazine hydrochloride with ascorby palmitate, colloidal silicon dioxide, white wax, hard fat, and glyceryl monostearate. They are administered rectally as directed and stored at 2°-8°C (36°-46°F). This product is distributed by Cosette Pharmaceuticals, Inc. and more information can be found on their website.*
FDA Label Image

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.